MedPath

Budesure

Brand Name: Budesure

Generic Name: Budesonide

Active
Registration Number

DRP-16544

Dosage Form

Suspension For Nebulization

Issuance Date

April 1, 2025

Expiry Date

April 22, 2030

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength250mcg/mL (500mcg/2mL)
PackagingLDPE Respule x 2 mL in Laminated Film Pouch Strip x 5's (Box of 20's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Drugs for obstructive airway disease (Glucocorticoid)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

BudesonideActive
Monograph: Budesonide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform